Zogenix reported $39.56M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 81.67M 15.12M
Acura Pharmaceuticals ACUR:US 523K 138K
Adamas Pharmaceuticals ADMS:US 29.73M 579K
Aerie Pharmaceuticals AERI:US $ 34.66M 114K
Alnylam Pharmaceuticals ALNY:US $ 142.07M 11.75M
Arena Pharmaceuticals ARNA:US $ 30.3M 1.63M
AstraZeneca AZN:LN 2.99B 412M
Becton, Dickinson and BDX:US $ 1.33B 95M
Biocryst Pharmaceuticals BCRX:US $ 34.99M 8.67M
Biogen BIIB:US $ 654.1M 16.8M
Cardinal Health CAH:US 1.11B 15M
Esperion Therapeutics ESPR:US $ 39.26M 7.05M
Flexion Therapeutics FLXN:US $ 26.99M 423K
GlaxoSmithKline GSK:LN 2.5B 6M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Heron Therapeutics HRTX:US $ 34.99M 1.84M
Intra Cellular Therapies ITCI:US $ 70.5M 646.73K
Johnson & Johnson JNJ:US $ 6B 73M
Marinus Pharmaceuticals MRNS:US 9.45M 2.62M
Merk MRK:US $ 2.27B 9M
Nektar Therapeutics NKTR:US $ 29.47M 87K
Neurocrine Biosciences NBIX:US $ 154.6M 11.4M
Pfizer PFE:US $ 2.73B 61M
Revance Therapeutics RVNC:US $ 51.12M 2.11M
Sarepta Therapeutics SRPT:US $ 61.13M 11.22M
Teva Pharmaceutical TEVA:IT 864M 32M
Zogenix ZGNX:US $ 39.56M 5.68M